Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
Online First
Web Exclusives
All Web Exclusives
Videos
Monthly Minutes
Conversations on CCA
Interview with the Innovators
Press Releases
CCA Summit
Cholangiocarcinoma Summit
Advancing the Fight Against Cholangiocarcinoma: Dr. Ghassan Abou-Alfa on Global Impact and Research Progress
Cholangiocarcinoma
Videos
— July 10, 2025
Featuring:
Ghassan K. Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
New York, NY
Dr. Ghassan Abou-Alfa, a renowned medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the global impact of cholangiocarcinoma and the pivotal role of the CCA Summit in driving research, collaboration, and improved patient care.
Related Items
Evolving Targeted Treatment Landscape in Biliary Tract Cancer
Cholangiocarcinoma
Web Exclusives
The podcast provides peer-to-peer physician perspectives on targeted treatments in BTC, focusing on fibroblast growth factor receptor (FGFR) inhibitors.
Read More
First-Line Treatment of Advanced Biliary Tract Cancers (BTCs)
Cholangiocarcinoma
Ask the Expert
Use of first-line (1L) IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin (gem-cis) chemotherapy in patients with locally advanced or metastatic biliary tract cancers
Read More
KEYNOTE-966: Pembrolizumab Combined With GemCis Versus GemCis Alone in Patients With BTC
Cholangiocarcinoma
2023 Year in Review: Cholangiocarcinoma
In the KEYNOTE-966 study, pembrolizumab was added to gemcitabine/cisplatin to assess outcomes in patients with advanced biliary tract cancer.
Read More
Post-hoc Analysis of the ABC-01, -02, and -03 Trials in Patients With Advanced eCCA
Cholangiocarcinoma
2023 Year in Review: Cholangiocarcinoma
This post-hoc analysis of the ABC-01, -02, and -03 clinical trials provides reference survival data for patients with advanced extrahepatic cholangiocarcinoma treated with first-line gemcitabine/cisplatin chemotherapy.
Read More
Efficacy and Safety of Tinengotinib in Patients With Advanced Refractory/Relapsed CCA Who Previously Received an FGFR Inhibitor
Cholangiocarcinoma
2023 Year in Review: Cholangiocarcinoma
Investigators pooled data from 3 trials to evaluate tinengotinib in patients with advanced, refractory/relapsed cholangiocarcinoma who previously received an FGFR inhibitor.
Read More
KLF5 Inhibition Reduces Tumor Growth and Sensitizes to Chemotherapy-Induced Cell Death in Experimental Models of CCA
Cholangiocarcinoma
2023 Year in Review: Cholangiocarcinoma
Researchers evaluated
KLF5
expression and its inhibition in cholangiocarcinoma using clustered regularly interspaced short palindromic repeats technology.
Read More
Phase 2 Trial of SHR-1316 Plus IBI310 in Patients With Advanced iCCA After Inadequate Response to First-Line Therapy
Cholangiocarcinoma
2023 Year in Review: Cholangiocarcinoma
In this ongoing phase 2 study, the efficacy of SHR-1316 plus IBI310 is being evaluated in patients with advanced intrahepatic cholangiocarcinoma after inadequate response to first-line therapy.
Read More
Examination of Patients With CCA Treated With Novel Targeted Therapies After Extended Molecular Profiling on Liquid Biopsies
Cholangiocarcinoma
2023 Year in Review: Cholangiocarcinoma
Dr Mahmood presented results from the largest multi-institutional review of efficacy outcomes following targeted agents in patients with cholangiocarcinoma.
Read More
Phase 2 Component of the BEER-BTC Study: Comparing Bevacizumab Plus Erlotinib Maintenance Versus Observation in Patients With Advanced BTC
Cholangiocarcinoma
2023 Year in Review: Cholangiocarcinoma
In the phase 2 component of the phase 2/3 BEER-BTC study, bevacizumab plus erlotinib improved outcomes in patients with advanced biliary tract cancers.
Read More
The DEBATE Trial: Neoadjuvant Durvalumab Plus GemCis Versus GemCis Alone for Patients With Localized BTC
Cholangiocarcinoma
2023 Year in Review: Cholangiocarcinoma
Researchers investigated the efficacy and safety of neoadjuvant durvalumab plus gemcitabine/cisplatin (GemCis) versus GemCis alone in patients with biliary tract cancer.
Read More
View the Latest Issue of CCA News
Read Issue
Home
Issues
Latest Issue
Issue Archive
Special Issues
Online First
Web Exclusives
All Web Exclusives
Videos
Monthly Minutes
Conversations on CCA
Interview with the Innovators
Press Releases
CCA Summit
Cholangiocarcinoma Summit
Subscribe Today!
To sign up for our newsletter or print publications, please enter your contact information below.
I'd like to receive:
CCA News
Print Edition
CCA News
Weekly e‑Newsletter
Profession or Role
- Please Select -
Administrator
Caregiver
Consumer
Health Business
Media/Press
Medical Student
Nurse Navigator
Nurse/APN
Other Healthcare Provider
Patient
Patient Navigator
Payer
Pharmacist
Physician
Physician Assistant
Social Worker
Survivor/Former Patient
Other (Not Listed)
Primary Specialty or Disease State
- Please Select -
Allergy & Clinical Immunology
Anal Cancer
Anesthesiology
BioOncology
Bladder Cancer
Bone Cancer
Brain/CNS Cancer
Breast Cancer
Carcinoma
Cardiology
Cervical Cancer
Cholangiocarcinoma
Colorectal Cancer
Community Pharmacy
Critical Care/Intensive Care
Dermatology
Diabetes
Emergency Medicine
Endocrinology
Endometrial Cancer
Esophageal Cancer
Family Medicine
Gastroenterology
Gastrointestinal Cancer
General Oncology
General Practice
Genitourinary Cancer
Genomic Medicine
Geriatrics
Gynecologic Cancer
Head and Neck Cancer
Hematology
Hepatology
HIV/AIDS
Hodgkin Disease
Hospice/Palliative Care
Hospital Pharmacy
Immune Thrombocytopenic Purpura
Immunology
Infectious Diseases
Internal Medicine
Kidney Cancer
Leukemia/Lymphoma
Liver Cancer
Lung Cancer
Melanoma
Multi-site Cancers
Multiple Myeloma
Myelodysplastic Syndrome
Myeloproliferative Disease
Neonatal/Perinatal Medicine
Nephrology
Neuroendocrine Cancer
Neurology
Neurosurgery
Non-Hodgkin Lymphoma
Nutrition
Ob/Gyn & Womens Health
Oncology Pharmacy
Ophthalmology
Orthopaedic Surgery
Otolaryngology
Ovarian Cancer
Pain Management
Pancreatic Cancer
Pathology
Pediatric Cancers
Pediatrics
Preventive Medicine
Prostate Cancer
Psychiatry/Mental Health
Public/Community Health
Pulmonary Medicine
Radiology
Renal Cell Carcinoma
Rheumatology
Sarcoma
Specialty Pharmacy
Surgery
Testicular Cancer
Thyroid Cancer
Transplantation
Urology
Urothelial Carcinoma
Vascular Medicine
Other (Not Listed)
-- Please Select Country --
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, the Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, the former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
I have reviewed and consent to the terms of
CCA News
's
Privacy Policy
, and
CCA News
has my permission to retain my information in its database, and to forward pertinent communications to me.
START YOUR SUBSCRIPTION
